Patient Buzz Series: FDA’s Topical Finasteride Alert
The FDA’s alert on the safety of topical finasteride is one of the dermatology news stories making headlines in the consumer press. New Beauty interviewed three dermatologists for their perspective on the popular hair loss treatment. Dermatologist Dr. Skylar Souyoul notes that topical finasteride does not have the same level of clinical study as oral finasteride. Dr. Natanel Jourabchi says it’ …
The FDA’s alert on the safety of topical finasteride is one of the dermatology news stories making headlines in the consumer press. New Beauty interviewed three dermatologists for their perspective on the popular hair loss treatment. Dermatologist Dr. Skylar Souyoul notes that topical finasteride does not have the same level of clinical study as oral finasteride. Dr. Natanel Jourabchi says it’ … Continue reading "Patient Buzz Series: FDA’s Topical Finasteride Alert"
A 35-year-old female presents to dermatology clinic for the pictured rash, which has been recurring at least once per week for the past six months. Which of the following treatment options works by reducing mast cell degranulation through Bruton tyrosine kinase inhibition?
A. Dupilumab
B. Benralizumab
C. Cromolyn sodium
D. … 
Sexually transmitted diseases are at a crisis state in patients with skin of color. That’s according to Dr. Theodore Rosen, professor of dermatology at Baylor College of Medicine and chief of dermatology service at Michael DeBakey Veterans Affairs Medical Center. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Rosen, who shared about three diseases that are at sweep … 
Last September, a co-resident and I had the opportunity to attend the annual congress of the European Academy of Dermatology and Venerology (EADV) in Amsterdam, The Netherlands. With over 17,300 attendees from over 50+ countries and a substantial contingent of “delegates” from Europe, Asia, and Africa, this was a truly diverse experience that showcased the best of dermatology from around the … 
Photosensitive skin conditions can result in cutaneous and systemic symptoms that can have a marked effect on quality of life due to ubiquitous UV exposure. Erythropoietic protoporphyria, for example, can cause severe photodermatitis, excruciating burning and neuropathic pain, nausea, and deep-rooted fear of sunlight that leads to debilitating lifestyle modifications such as remaining indoors. We …